Cargando…

Platelet‐activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy?

Detalles Bibliográficos
Autores principales:	Bilò, Maria Beatrice, Corsi, Alice, Martini, Matteo, Danieli, Maria Giovanna, Alia, Sonila, Di Paolo, Alice, Moroncini, Gianluca, Vignini, Arianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299147/ https://www.ncbi.nlm.nih.gov/pubmed/34716604 http://dx.doi.org/10.1111/all.15161

Ejemplares similares

Development of a model care pathway for the management of Hymenoptera venom allergy: evidence-based key interventions and indicators
por: Bilò, Maria Beatrice, et al.
Publicado: (2020)

Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom Allergy
por: Blank, Simon, et al.
Publicado: (2020)

Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes
por: Blank, Simon, et al.
Publicado: (2020)

Platelets and platelet-activating factor acetylhydrolase in septic patients
por: Ruβwurm, S, et al.
Publicado: (1999)

Risk factors in Hymenoptera venom allergy
por: Ruëff, F., et al.
Publicado: (2017)

Benefits and limitations of sting challenge in hymenoptera venom allergy
por: Aßmus, Katharina, et al.
Publicado: (2021)

Relationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy
por: Perelman, Boris, et al.
Publicado: (2014)

The Influence of Age and Oral Health on Taste Perception in Older Adults: A Case-Control Study
por: Alia, Sonila, et al.
Publicado: (2021)

Component resolved diagnostics for hymenoptera venom allergy
por: Jakob, Thilo, et al.
Publicado: (2017)

Proteomic features characterization of Hymenoptera venom allergy
por: Matuszewska, Eliza, et al.
Publicado: (2019)

Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome.
por: Trimoreau, F, et al.
Publicado: (2000)

Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome
por: Ames, Paul R. J., et al.
Publicado: (2018)

Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy
por: Paolocci, Giulia, et al.
Publicado: (2014)

Shedding Light on the Venom Proteomes of the Allergy-Relevant Hymenoptera Polistes dominula (European Paper Wasp) and Vespula spp. (Yellow Jacket)
por: Grosch, Johannes, et al.
Publicado: (2020)

Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients
por: Danieli, Maria Giovanna, et al.
Publicado: (2022)

Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience
por: Danieli, Maria Giovanna, et al.
Publicado: (2022)

Current practices in diagnosis of Hymenoptera venom allergy in Poland
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2021)

The ALA5/ALA6/ALA7 repeat polymorphisms of the glutathione peroxidase‐1 ( GPx1 ) gene and autism spectrum disorder
por: Carducci, Federica, et al.
Publicado: (2022)

Pathogenic Role of the Sphingosine 1-Phosphate (S1P) Pathway in Common Gynecologic Disorders (GDs): A Possible Novel Therapeutic Target
por: Di Paolo, Alice, et al.
Publicado: (2022)

Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens
por: Perez-Riverol, Amilcar, et al.
Publicado: (2015)

Diagnosis of Hymenoptera Venom Allergy: State of the Art, Challenges, and Perspectives
por: Matysiak, Joanna, et al.
Publicado: (2022)

Stinging insect identification in children with Hymenoptera venom allergy and their parents
por: Kaszuba, Jagoda, et al.
Publicado: (2023)

Health-related quality of life in Polish adolescents with Hymenoptera venom allergy treated with venom immunotherapy
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2012)

Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases
por: Vergne, P., et al.
Publicado: (1997)

Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery
por: Tsoukatos, Demokritos C., et al.
Publicado: (2008)

Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B
por: Feng, Limin, et al.
Publicado: (2014)

90 Improving the Diagnosis of Hymenoptera Venom Allergy: Component Resolved Diagnosis
por: Cifuentes, Liliana, et al.
Publicado: (2012)

New Biomarkers of Hymenoptera Venom Allergy in a Group of Inflammation Factors
por: Packi, Kacper, et al.
Publicado: (2021)

Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics
por: Jakob, Thilo, et al.
Publicado: (2017)

A Pilot Cross-Sectional Study on Oral Health and Nutritional Status of Institutionalized Older Adults: A Focus on Sarcopenia
por: Aquilanti, Luca, et al.
Publicado: (2021)

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
por: Yavuz, Suleyman Tolga, et al.
Publicado: (2014)

Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
por: Sahiner, Umit Murat, et al.
Publicado: (2019)

Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy
por: Eitel, Tamara, et al.
Publicado: (2021)

Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies
por: Fabris, Martina, et al.
Publicado: (2017)

Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia
por: Tano, Kanako, et al.
Publicado: (2019)

Development of children’s hymenoptera venom allergy quality of life scale (CHVAQoLS)
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2013)

Allergen-specific immunotherapy of Hymenoptera venom allergy – also a matter of diagnosis
por: Schiener, Maximilian, et al.
Publicado: (2017)

Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
por: Jovanovic, Dragana, et al.
Publicado: (2023)

Hymenoptera Venom Immunotherapy in Dogs: Safety and Clinical Efficacy
por: Rostaher, Ana, et al.
Publicado: (2023)

Hymenoptera Allergens: From Venom to “Venome”
por: Spillner, Edzard, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gfhp2m03iijksspscu93io399i